Successful treatment of massive acute upper gastrointestinal bleeding in liver failure with activated recombinant factor VII (NovoSeven): a case report

被引：3

作者：

Tonkic, A

Jukic, I

Titlic, M

Mise, S

机构：

[1] Clin Hosp Split, Dept Internal Med, Div Gastroenterol & Hepatol, Split 21000, Croatia

[2] Clin Hosp Split, Dept Neurol, Split 21000, Croatia

来源：

BLOOD COAGULATION & FIBRINOLYSIS | 2005年 / 16卷 / 05期

关键词：

activated recombinant factor VII; acute upper gastrointestinal bleeding; portal hypertensive gastropathy; liver failure;

D O I：

10.1097/01.mbc.0000172098.04040.da

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：385 / 387

页数：3

共 50 条

[31] Activated recombinant factor VII (rFVIIa/NovoSeven®) in the treatment of bleeding complications following hematopoietic stem cell transplantation (HSCT)
Brenner, B
Pihusch, M
Bacigalupo, A
Szer, J
Prondzinski, MV
Gaspar-Blaudschun, B
Hyveled, L
BLOOD, 2004, 104 (11) : 321A - 322A
[32] Health economic review of recombinant activated factor VII (Novoseven®) for treatment of bleeding episodes in hemophilia patients with inhibitors.
Stephens, Jennifer M.
Botteman, Marc F.
Joshi, Ashish V.
Sumner, Michael
BLOOD, 2006, 108 (11) : 482B - 482B
[33] Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding - a European perspective
Vincent, Jean-Louis
Rossaint, Rolf
Riou, Bruno
Ozier, Yves
Zideman, David
Spahn, Donat R.
CRITICAL CARE, 2006, 10 (04)
[34] Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective
Jean-Louis Vincent
Rolf Rossaint
Bruno Riou
Yves Ozier
David Zideman
Donat R Spahn
Critical Care, 10
[35] Successful treatment of recurrent preoperative bleeding of glioblastoma with recombinant activated factor VII: pathophysiological hypothesis
Baptiste Duceau
Stephane Welschbillig
Nicolas Engrand
Anne Godier
Acta Neurochirurgica, 2015, 157 : 2023 - 2024
[36] Successful outcome of using recombinant activated factor VII (rFVIIa) in liver biopsy in a patient with liver failure
Al Sobhi, E.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (09) : 2073 - 2074
[37] Successful treatment of recurrent preoperative bleeding of glioblastoma with recombinant activated factor VII: pathophysiological hypothesis
Duceau, Baptiste
Welschbillig, Stephane
Engrand, Nicolas
Godier, Anne
ACTA NEUROCHIRURGICA, 2015, 157 (11) : 2023 - 2024
[38] Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven®) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
D Thabut
R de Franchis
F Bendtsen
G D'Amico
A Albillos
JG Abraldes
S Sofelt
J Bosch
Critical Care, 8 (Suppl 1):
[39] Efficacy of activated recombinant factor VII (rFVIIa; Novoseven®) in cirrhotic patients with upper gastrointestinal bleeding:: A randomized placebo-controlled double-blind multicenter trial
Thabut, D
De Franchis, R
Bendtsen, F
D'Amico, G
Albillos, A
Abraldes, JG
Fabricius, S
Bosch, J
GASTROENTEROLOGY, 2003, 124 (04) : A697 - A697
[40] Recombinant factor VIIa (NovoSeven(R)) in the treatment of internal bleeding in patients with factor VII and IX inhibitors
Lusher, JM
HAEMOSTASIS, 1996, 26 : 124 - 130

← 1 2 3 4 5 →